News Agency News Aggregator Journalist/Editor Broking House Others
Spoke to AUROPHARMA on Vaccines. Existing capacity is 220 million vials for 1 year but limited they can do Fill Finish for other manufacturers currently. New full Vaccine facility of 260 million vials will be ready in May and start of commercial production is possible in June.
At 16x P/E and 2x Market Cap to Sales, AUROPHARMA is one of the cheapest pharma stocks among biggies.
Auropharma - CMP 916 Stock is bouncing from moving average support. Short-term moving averages are pointing towards the sky, a big move on the upside is possible in this stock, There is a pending Vaccine announcement and today demerger news. SL 880 TARGET 1000+
AUROPHARMA cmp 919 Should travel to the moon!
Post demerger Aurobindo plans to focus on Biosimilar business Aurobindo Pharma yet to comment on queries sent by CNBC Awaaz
Aurobindo Pharma: Sources to @CNBC_Awaaz Plans to demerge Injectables business unit In talks with investment bankers for demerger plan for Injectables Plans to create shareholder value unlocking via demerger May soon take proposal of demerger with board after initial talks
#chartoftheday #auropharma has a bullish trend above 920, check out the chart, #bullishpattern, pharma sector, #risingvolume, #supportivemomentumindicator and #askExpertAtGEPLCapital to know more.
Aurobindo Pharma में जबरदस्त एक्शन... सटीक रही अनिल सिंघवी की खरीदारी की राय... हमारा मकसद बस पैसा बनना चाहिए आपका... #AurobindoPharma #TargetHit @AnilSinghvi_
#Auropharma high today 950++
D-Street Chatter | @nimeshscnbc gets you insights from the dealing rooms and tells us why stocks like Aurobindo Pharma & Gujarat Alkalies are buzzing in the trade
949 high #auropharma done dusted
940 final trgt zone of aurobindo
894 to 927++#auropharma book or trail is your choice!!
894 to 918+++ #auropharma enjoy !!
#SharekhanResearch #Q4FY21 Pharma Preview, API focused companies to drive the growth, India focused cos with high chronic presence to grow at healthy pace; Pref picks Aurobindo, Cipla, Divis, Laurus Labs, Dr Reddys, Lupin, Sanofi India, Abbott India, Strides Pharma,Gland Pharma
AUROBINDO PHARMA: PROMOTER GROUP CREATED PLEDGE OF 350,000 SHARES ON APR 3
Stock Of The Day: Buy Aurobindo Pharma Futures: SL 895 Tgt 925, 940 Pharma stocks strong, Pre-result buying expected @ZeeBusiness
#jswsteel hit 560... our target given in above post was just 540. Hope you enjoyed this momentum call. For getting such calls daily [email protected] Today we enjoyed SBILife 795 to 823, AuroPharma 890 to 915, BEL 129 to 135, PFC 114 to 117.5 and many others.